Live Breaking News & Updates on Robert Patrick Jones Goldman Sachs Group Analyst

Operator
Welcome to the McKesson Q4 Earnings Call. Today s conference is being recorded. At this time, I d like to turn the conference over to you, Holly Weiss. Please go ahead.
Holly Weiss
Vice President-Investor Relations
Thank you, Stephanie. Good afternoon and welcome, everyone, to McKesson s Fourth Quarter Fiscal 2021 Earnings Call. Today, I m joined by Brian Tyler, our Chief Executive Officer; and Britt Vitalone, our Chief Financial Officer. Brian will lead off, followed by Britt, and then we will move to a question-and-answer session. Today s discussion will include forward-looking statements, such as forecasts about McKesson s operations and future results. Please refer to the cautionary statements in today s press release and our slide presentation and to the Risk Factors section of our periodic SEC filings for additional information concerning risk factors that could cause our actual results to materially differ from those in our forward-looking statem ....

United States , Mike Cherny , Britt Vitalone , Robert Jones , Brian Tyler , Lisa Christine Gill Jpmorgan , Brians Tyler , Lisa Gill , Brittj Vitalone , Holly Weiss , Mckesson Europe , Goldman Sachs , Surgical Solutions , Prescription Technology Solutions , Walgreens Boots Alliance , Mckesson Corp , Us Oncology Network , Technology Solutions , Robert Patrick Jones Goldman Sachs Group Analyst , Fourth Quarter Fiscal , Chief Executive Officer , Chief Financial , Risk Factors , Emergency Use Authorization , Relayhealth Pharmacy , Prescription Technology ,